LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 50.36 | 84.90 | 1550 | 5651 | 0.2743 | 0.6154 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 52.06 | 84.90 | 1223 | 5990 | 0.2042 | 0.5440 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 52.06 | 84.90 | 1240 | 5990 | 0.2070 | 0.5475 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 52.06 | 84.90 | 1559 | 5990 | 0.2602 | 0.6063 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 52.06 | 84.90 | 1588 | 5990 | 0.2651 | 0.6111 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.77 | 84.90 | 1240 | 6252 | 0.1983 | 0.5408 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.77 | 84.90 | 1258 | 6252 | 0.2012 | 0.5444 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.77 | 84.90 | 1615 | 6252 | 0.2583 | 0.6079 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.77 | 84.90 | 1634 | 6252 | 0.2613 | 0.6109 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.48 | 84.90 | 1254 | 6567 | 0.1909 | 0.5360 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.48 | 84.90 | 1269 | 6567 | 0.1932 | 0.5390 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.48 | 84.90 | 1680 | 6567 | 0.2558 | 0.6093 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.48 | 84.90 | 1695 | 6567 | 0.2581 | 0.6116 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 57.18 | 84.90 | 1302 | 6963 | 0.1870 | 0.5364 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 57.18 | 84.90 | 1315 | 6963 | 0.1889 | 0.5388 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 57.18 | 84.90 | 1734 | 6963 | 0.2490 | 0.6072 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 57.18 | 84.90 | 1751 | 6963 | 0.2515 | 0.6097 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.88 | 84.90 | 1356 | 7291 | 0.1860 | 0.5393 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.88 | 84.90 | 1372 | 7291 | 0.1882 | 0.5421 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.88 | 84.90 | 1782 | 7291 | 0.2444 | 0.6061 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.88 | 84.90 | 1799 | 7291 | 0.2467 | 0.6085 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.59 | 84.90 | 1415 | 7641 | 0.1852 | 0.5424 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.59 | 84.90 | 1431 | 7641 | 0.1873 | 0.5451 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.59 | 84.90 | 1803 | 7641 | 0.2359 | 0.6011 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.59 | 84.90 | 1818 | 7641 | 0.2379 | 0.6032 | MN20160318_Q02 | I05 |